| Bonita Springs Hospice Care Llc 8545 Monterey Road, Suite B, Gilroy, CA, 95020 | |
| (408) 848-1114 |
News Archive
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
In New York, insurer requests for rate increases on the health law's exchange averaged 13 percent, while Denver Health is asking state regulators for a 17.5 percent hike next year. Georgia has a different story: Two companies are planning to enter the exchange next year and Blue Cross, the only statewide plan on the exchange this year, says it will drop rates by 7 percent.
Amazon Filters reports on how its SupaPore VPBA sterile filter cartridge is enabling a veterinary pharmaceutical manufacturer to process its batches faster while still maintaining the quality of the final products.
Researchers at Sweden's Karolinska Institutet and the University of British Columbia, Canada, have identified a gene variant that influences whether Huntington's disease breaks out earlier or later than expected. The findings, which are published in the scientific journal Nature Neuroscience, can contribute to improved diagnosis and disease-modifying therapies.
› Verified 4 days ago
| Name | Bonita Springs Hospice Care Llc |
|---|---|
| Location | 8545 Monterey Road, Suite B, Gilroy, California |
| Hospice ID | 751672 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 530 |
News Archive
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
In New York, insurer requests for rate increases on the health law's exchange averaged 13 percent, while Denver Health is asking state regulators for a 17.5 percent hike next year. Georgia has a different story: Two companies are planning to enter the exchange next year and Blue Cross, the only statewide plan on the exchange this year, says it will drop rates by 7 percent.
Amazon Filters reports on how its SupaPore VPBA sterile filter cartridge is enabling a veterinary pharmaceutical manufacturer to process its batches faster while still maintaining the quality of the final products.
Researchers at Sweden's Karolinska Institutet and the University of British Columbia, Canada, have identified a gene variant that influences whether Huntington's disease breaks out earlier or later than expected. The findings, which are published in the scientific journal Nature Neuroscience, can contribute to improved diagnosis and disease-modifying therapies.
› Verified 4 days ago
| NPI Number | 1083014864 |
| Organization Name | Bonita Springs Hospice Care Llc |
| Address | 8545 Monterey St Gilroy, California, 95020 |
| Phone Number | (408)848-1114 |
News Archive
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
In New York, insurer requests for rate increases on the health law's exchange averaged 13 percent, while Denver Health is asking state regulators for a 17.5 percent hike next year. Georgia has a different story: Two companies are planning to enter the exchange next year and Blue Cross, the only statewide plan on the exchange this year, says it will drop rates by 7 percent.
Amazon Filters reports on how its SupaPore VPBA sterile filter cartridge is enabling a veterinary pharmaceutical manufacturer to process its batches faster while still maintaining the quality of the final products.
Researchers at Sweden's Karolinska Institutet and the University of British Columbia, Canada, have identified a gene variant that influences whether Huntington's disease breaks out earlier or later than expected. The findings, which are published in the scientific journal Nature Neuroscience, can contribute to improved diagnosis and disease-modifying therapies.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 76.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 93.3 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 80.4 | 97.3 |
| Patients who got timely treatment for shortness of breath | 89.3 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
In New York, insurer requests for rate increases on the health law's exchange averaged 13 percent, while Denver Health is asking state regulators for a 17.5 percent hike next year. Georgia has a different story: Two companies are planning to enter the exchange next year and Blue Cross, the only statewide plan on the exchange this year, says it will drop rates by 7 percent.
Amazon Filters reports on how its SupaPore VPBA sterile filter cartridge is enabling a veterinary pharmaceutical manufacturer to process its batches faster while still maintaining the quality of the final products.
Researchers at Sweden's Karolinska Institutet and the University of British Columbia, Canada, have identified a gene variant that influences whether Huntington's disease breaks out earlier or later than expected. The findings, which are published in the scientific journal Nature Neuroscience, can contribute to improved diagnosis and disease-modifying therapies.
› Verified 4 days ago
| Home Health Aides | 0.75 |
| Counselors | 0.01 |
| Medical Social Workers | 0.4 |
| Physicians | 0.1 |
| Registered Nurses | 0.5 |
| Other Personnel | 3 |
| Total Employees | 4.76 |
|---|
News Archive
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
In New York, insurer requests for rate increases on the health law's exchange averaged 13 percent, while Denver Health is asking state regulators for a 17.5 percent hike next year. Georgia has a different story: Two companies are planning to enter the exchange next year and Blue Cross, the only statewide plan on the exchange this year, says it will drop rates by 7 percent.
Amazon Filters reports on how its SupaPore VPBA sterile filter cartridge is enabling a veterinary pharmaceutical manufacturer to process its batches faster while still maintaining the quality of the final products.
Researchers at Sweden's Karolinska Institutet and the University of British Columbia, Canada, have identified a gene variant that influences whether Huntington's disease breaks out earlier or later than expected. The findings, which are published in the scientific journal Nature Neuroscience, can contribute to improved diagnosis and disease-modifying therapies.
› Verified 4 days ago
| Others | 0.02 |
| Total Volunteers | 0.02 |
|---|
News Archive
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
In New York, insurer requests for rate increases on the health law's exchange averaged 13 percent, while Denver Health is asking state regulators for a 17.5 percent hike next year. Georgia has a different story: Two companies are planning to enter the exchange next year and Blue Cross, the only statewide plan on the exchange this year, says it will drop rates by 7 percent.
Amazon Filters reports on how its SupaPore VPBA sterile filter cartridge is enabling a veterinary pharmaceutical manufacturer to process its batches faster while still maintaining the quality of the final products.
Researchers at Sweden's Karolinska Institutet and the University of British Columbia, Canada, have identified a gene variant that influences whether Huntington's disease breaks out earlier or later than expected. The findings, which are published in the scientific journal Nature Neuroscience, can contribute to improved diagnosis and disease-modifying therapies.
› Verified 4 days ago
| Bonita Springs Hospice Care Llc Location: 8545 Monterey Road, Suite B, Gilroy, California, 95020 Phone: (408) 848-1114 |